Literature DB >> 8434099

Insurance coverage of special foods needed in the treatment of phenylketonuria.

B N Millner1.   

Abstract

Optimal medical management of phenylketonuria (PKU) requires the use of special low-phenylalanine foods for many years. For women with PKU, elevated maternal blood levels of phenylalanine even at conception can lead to fetal damage. Despite this need, private health insurance, Medicaid, and other public health programs often exclude the cost of these foods from their benefits. The New York State Department of Health conducted a survey of metabolic disorders treatment centers to elucidate the problems PKU patients have obtaining and paying for the special foods essential to their care. Payment for special foods was denied to nearly half of those with private health insurance policies and was covered for only 10 percent of Medicaid-eligibles. A public program for children with special health care needs covered these food costs in upstate New York but not in New York City. There is no program of assistance for adults who are not eligible for Medicaid and who do not have private insurance coverage of special foods. At present, many private health insurance policies and public programs do not cover the costs of low-phenylalanine foods other than infant formula. Payment for this essential part of the management of PKU should be mandated for all public programs for persons with chronic illnesses, public medical assistance (Medicaid) programs, and private health insurance. There is a need for a public program to assist adults with PKU who are not eligible for Medicaid and who do not have health insurance that covers these costs.

Entities:  

Mesh:

Year:  1993        PMID: 8434099      PMCID: PMC1403331     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  Continuation vs discontinuation of diet in phenylketonuria.

Authors:  E R Naughten
Journal:  Eur J Clin Nutr       Date:  1989       Impact factor: 4.016

2.  Effects of untreated maternal hyperphenylalaninemia on the fetus: further study of families identified by routine cord blood screening.

Authors:  S E Waisbren; H L Levy
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

3.  Maternal PKU--a continuing problem.

Authors:  R Guthrie
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

4.  Return to diet therapy in patients with phenylketonuria.

Authors:  K Michals; M Dominik; V Schuett; E Brown; R Matalon
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

5.  Diet discontinuation policies and practices of PKU clinics in the United States.

Authors:  V E Schuett; R F Gurda; E S Brown
Journal:  Am J Public Health       Date:  1980-05       Impact factor: 9.308

6.  Semen studies on phenylketonurics.

Authors:  R O Fisch; M Y Tsai; B A Clark; T Okagaki
Journal:  Biochem Med       Date:  1981-12

Review 7.  Transport of amino acids by the human placenta: predicted effects thereon of maternal hyperphenylalaninaemia.

Authors:  Y Kudo; C A Boyd
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

8.  Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study.

Authors:  K Michals; C Azen; P Acosta; R Koch; R Matalon
Journal:  J Am Diet Assoc       Date:  1988-10

9.  Reinstitution of diet therapy in PKU patients from twenty-two US clinics.

Authors:  V E Schuett; E S Brown; K Michals
Journal:  Am J Public Health       Date:  1985-01       Impact factor: 9.308

10.  The New England Maternal PKU Project: identification of at-risk women.

Authors:  S E Waisbren; L B Doherty; I V Bailey; F J Rohr; H L Levy
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

View more
  3 in total

Review 1.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

2.  Newborn screening: complexities in universal genetic testing.

Authors:  Nancy S Green; Siobhan M Dolan; Thomas H Murray
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

3.  Pain points in parents' interactions with newborn screening systems: a qualitative study.

Authors:  Mike Conway; Truc Thuy Vuong; Kim Hart; Andreas Rohrwasser; Karen Eilbeck
Journal:  BMC Pediatr       Date:  2022-03-31       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.